Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
An Bras Dermatol ; 92(3): 323-328, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29186242

RESUMO

BACKGROUND: S100B protein was reported to be elevated in psoriatic patients' serum, with no previous evaluation of its skin expression, in contrast to the extensively studied S100 protein. OBJECTIVE: To evaluate the serum level and skin expression of S100B in psoriasis to assess its possible involvement in its pathogenesis. METHODS: Serum level of S100B protein was estimated in 40 psoriatic patients of different clinical varieties and 10 healthy controls. S100B protein expression was assessed immunohistochemically in lesional and non-lesional skin of patients and in normal skin of controls. Relation to disease severity was also evaluated. RESULTS: Serum level of S100B protein was significantly higher in psoriatic patients (0.15±0.03 µg/l) than in controls (0.03±0.007 µg/l) (P-value <0.001) with no significant correlation with PASI score. On comparing grades of S100B protein skin expression in lesional and non-lesional skin biopsies, a statistically significant difference was found (P=0.046) with higher percentage of strong S100B skin expression (60%) in non-lesional than in lesional (42%) skin. All the control biopsies showed negative expression. STUDY LIMITATIONS: Relatively small sample size with a limited range of low PASI scores. CONCLUSION: This study points to a potential link between psoriasis and S100B protein with higher serum and skin expression in patients than in controls.


Assuntos
Psoríase/sangue , Subunidade beta da Proteína Ligante de Cálcio S100/sangue , Adolescente , Adulto , Idoso , Biomarcadores/sangue , Biópsia , Estudos de Casos e Controles , Criança , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Psoríase/patologia , Índice de Gravidade de Doença , Adulto Jovem
2.
An. bras. dermatol ; 92(3): 323-328, May-June 2017. tab, graf
Artigo em Inglês | LILACS | ID: biblio-886968

RESUMO

Abstract Background: S100B protein was reported to be elevated in psoriatic patients' serum, with no previous evaluation of its skin expression, in contrast to the extensively studied S100 protein. Objective: To evaluate the serum level and skin expression of S100B in psoriasis to assess its possible involvement in its pathogenesis. Methods: Serum level of S100B protein was estimated in 40 psoriatic patients of different clinical varieties and 10 healthy controls. S100B protein expression was assessed immunohistochemically in lesional and non-lesional skin of patients and in normal skin of controls. Relation to disease severity was also evaluated. Results: Serum level of S100B protein was significantly higher in psoriatic patients (0.15±0.03 µg/l) than in controls (0.03±0.007 µg/l) (P-value <0.001) with no significant correlation with PASI score. On comparing grades of S100B protein skin expression in lesional and non-lesional skin biopsies, a statistically significant difference was found (P=0.046) with higher percentage of strong S100B skin expression (60%) in non-lesional than in lesional (42%) skin. All the control biopsies showed negative expression. Study limitations: Relatively small sample size with a limited range of low PASI scores. Conclusion: This study points to a potential link between psoriasis and S100B protein with higher serum and skin expression in patients than in controls.


Assuntos
Humanos , Masculino , Feminino , Criança , Adolescente , Adulto , Pessoa de Meia-Idade , Idoso , Adulto Jovem , Psoríase/sangue , Subunidade beta da Proteína Ligante de Cálcio S100/sangue , Psoríase/patologia , Biópsia , Índice de Gravidade de Doença , Ensaio de Imunoadsorção Enzimática , Imuno-Histoquímica , Biomarcadores/sangue , Estudos de Casos e Controles
3.
J Cosmet Dermatol ; 16(2): 279-286, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28374517

RESUMO

BACKGROUND: Striae distensae (SD), a type of dermal scarring, are psychologically disappointing. To date, information and scientific research behind the role of hormonal factors in the development of SD are still unclear. It is vital to understand striae to offer patients the best therapeutic options. OBJECTIVES: To investigate early alterations regarding the expression of estrogen, androgen, and glucocorticoid receptors (estrogen receptor (ER), androgen receptor (AR), glucocorticoid receptor (GR) in skin samples of multigravida (MG) and nulligravida (NG) cases and to compare them with normal controls. METHODS: This study included 30 subjects (10 MG and 10 NG cases with early SD and 10 healthy controls). Biopsies from SD lesions, perilesional normal skin of cases and normal skin of controls were examined immunohistochemically for ER, AR, and GR expression using immune peroxidase technique. RESULTS: Comparing MG and NG with controls, ER expression appeared reduced in MG and NG (P-value<.001), AR was elevated in MG (P-value<.05) with no considerable difference in NG (P-value>.05), while GR was elevated in both MG and NG (P-value<.05). On comparing perilesional skin with SD lesions in each of MG and NG groups, SD lesions revealed reduced ER expression in both groups (P-value<.05), whereas in MG group: AR expression was elevated with no difference detected regarding GR (P-value˃.05); meanwhile in NG, elevated expression in both AR and GR expression was noted (P-Value<.001) CONCLUSIONS: Striae distansae lesions demonstrated a significant increase in the expression of AR and GR and a declined expression of ER indicating their involvement in the development of early SD.


Assuntos
Receptores Androgênicos/análise , Receptores de Estrogênio/análise , Receptores de Glucocorticoides/análise , Estrias de Distensão/patologia , Adulto , Feminino , Número de Gestações , Humanos , Imuno-Histoquímica , Gravidez , Receptores Androgênicos/biossíntese , Receptores de Estrogênio/biossíntese , Receptores de Glucocorticoides/biossíntese , Estrias de Distensão/metabolismo , Adulto Jovem
4.
J Cosmet Dermatol ; 12(4): 254-60, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24305423

RESUMO

BACKGROUND: Natural ultraviolet exposure induces hair damage, which is difficult to avoid. Most of the research work is focused on the effect of ultraviolet on the epidermis, dermis as well as the immune system, whereas the long-term effect of ultraviolet on hair has not been investigated. AIM: we performed our experiment to find out the changes induced in hair follicle and shaft in those patients exposed to high doses of ultraviolet (A and B) during treatment of other skin conditions. PATIENTS AND METHODS: Light and transmission electron microscopy examination of scalp hair follicles and shafts of 10 patients with vitiligo under psoralen plus ultraviolet A (group 1) and 10 patients with vitiligo under narrow band ultraviolet B (group 2) was carried out and compared with those of 10 healthy volunteers (group 3). RESULTS: Physical changes in the appearance of hair were more in groups 1 and 2 than control. Reduced hair follicle thickness and perifollicular infiltrate and hyaline disorganized perifollicular collagen were observed more in group 1 than in group 2 with the absence of these changes in group 3. Transmission electron microscopy showed nonspecific cell injury in hair follicles in group 1 more than the other 2 groups, while the damaging effect on hair was more in the second group than the others. CONCLUSION: Due to the damaging effect of ultraviolet on hair, patients under treatment with this modality should be cautious to protect their hair during treatment.


Assuntos
Folículo Piloso/efeitos da radiação , Folículo Piloso/ultraestrutura , Cabelo/efeitos da radiação , Cabelo/ultraestrutura , Terapia Ultravioleta/efeitos adversos , Vitiligo/radioterapia , Adulto , Feminino , Ficusina/uso terapêutico , Cabelo/química , Humanos , Microscopia Eletrônica , Microscopia Eletrônica de Transmissão , Fármacos Fotossensibilizantes/uso terapêutico , Couro Cabeludo/efeitos da radiação , Terapia Ultravioleta/métodos
5.
Photodermatol Photoimmunol Photomed ; 27(5): 226-30, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21950625

RESUMO

BACKGROUND/PURPOSE: The value of psoriatic plaques pretreatment with specific topical preparations in the setting of NB-ultraviolet-B (UVB) therapy is debatable. It may be clarified through a comparative assessment between crude coal tar and petrolatum as pretreatment candidates. METHODS: A prospective study included 40 patients with plaque psoriasis undergoing NB-UVB therapy. We compared among three treatment regimens: NB-UVB alone (control group; n=20) as well as NB-UVB preceded by crude coal tar 3% on one side and petrolatum on the other side (cases group I and II; n=20). Tar and petrolatum were topically applied thrice/day the day before NB-UVB exposure. Applications were removed using olive oil directly before NB-UVB exposure. Regimens' frequency was thrice/week and the clinical outcome was assessed, through both psoriasis area and severity index (PASI) and physician global assessment (PGA) scores, at baseline and 3 months later. RESULTS: There were significant (P<0.01) decreases in both PASI and PGA scores in all the groups. In comparison with the controls, cases revealed significantly (P<0.05) higher improvement percentages in both PASI and PGA scores for both tar and petrolatum. This influence, through the PGA score, was significantly (P<0.05) in favor of petrolatum. CONCLUSION: The pretreatment of psoriatic plaques with either petrolatum or crude coal tar may enhance the therapeutic outcome of NB-UVB, which appeared to favor petrolatum.


Assuntos
Alcatrão/administração & dosagem , Emolientes/administração & dosagem , Ceratolíticos/administração & dosagem , Vaselina/administração & dosagem , Psoríase/radioterapia , Terapia Ultravioleta/métodos , Administração Tópica , Adulto , Método Duplo-Cego , Feminino , Humanos , Masculino , Estudos Prospectivos , Raios Ultravioleta
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...